Change Website:
Lab21 Home
Lab21 Clinical Laboratory
Lab21 Diagnostic Products
Lab21 Investor Relations
Search:
Site
Web
Home
Services
News & Events
About Us
Contact Us
Email Alerts
You are here:
Clinical Lab
>
Services
>
Pharma & CROs
>
Companion Diagnostics
Companion Diagnostics
Lab21 has full capability to take companion diagnostic assays or biomarker assays from concept through to clinical trials and to validated, regulatory approved diagnostic assays for commercial distribution.
Companion diagnostics are increasingly important, and often essential in the delivery of highly efficient and safe drug therapies.
Companion diagnostics are used to:
Stratify patients based on predicted efficacy or toxicity
Monitor drug efficacy
Monitor drug levels
Monitor response to therapy
Monitor toxicity
The phrase ‘Companion Diagnostic’ is typically applied to a laboratory assay that is required by FDA and/or EMEA for patient stratification to a specific, targeted drug or drugs. Other assays used in a similar way to ensure drug efficacy and safety include pharmacogenetics, drug resistance and therapeutic drug monitoring testing.
Lab21 services in Companion Diagnostics
Assay development
Clinical trial testing
Regulatory approval
Manufacture
Commercialisation
Global distribution
Support for drug market entry
Lab21 has full quality accreditations for the development, manufacture, and provision of di
agnostic products and services for the global market.
Lab21 is a vertically integrated diagnostics company
Lab21 provides a vertically integrated service that can support Clients throughout clinical trials and beyond by providing biomarker analysis, development of the biomarker into a regulatory approved assay, global distribution network and service direct to healthcare providers to support the marketing of the drug post launch.
Lab21 Clinical Laboratory
supports clients in Pharma, Biotech and CRO’s in the provision of specialist clinical diagnostics from the pre-clinical phase to Phase IV and beyond. Utilising custom built, fully equipped diagnostic and pharmacology laboratories with Cat II and Cat III facilities, we offer immediate access to our scientific knowledge, assay development, clinical trial and project management expertise.
Lab21 Diagnostic Products
manufactures regulatory approved immuno- and molecular diagnostic assays which are distributed globally through an extensive, global network of OEM and Distribution partners in addition to a direct sales force in Europe and the United States.
Lab21 and Vertically Integrated Diagnostics
Contact Us
Click here to Email
T
+44 (0)1223 395450
Hot Topic
Oncology Companion Diagnostics >
Pharma & CRO Services
Service Overview
Companion Diagnostics
Overview
Assay Development
Clinical Trials
Regulatory Approval
Commercialisation
Market Entry
Clinical Trials
Overview
Molecular Diagnostics
Pharmacogenetics
Pharmacology
Viral Drug Resistance
Immunodiagnostics
Preclinical Lead Identification
Therapy Areas
All Therapy Areas
Oncology Experience
HIV Experience
Viral Hepatitis Experience
Lab21
as Your Partner
Partnering with Lab21
Project Management
Data Management & Sample Logistics
Custom Projects and Consultancy